Skip to Content

99 Results Found

  • Communication
  • Open Access
1 Citations
2,883 Views
13 Pages

23 April 2024

Although lymphoma is the most frequent malignancy in common variable immunodeficiency (CVID), solid tumors, especially affected by oncogenic viruses, are not considered. Furthermore, in vitro genetic studies and cell cultures are not adequate for imm...

  • Article
  • Open Access
12 Citations
5,895 Views
19 Pages

15 October 2021

Hepatitis B virus (HBV) infection remains a major public health threat in the Middle East and North Africa (MENA). Phylogenetic analysis of HBV can be helpful to study the putative transmission links and patterns of inter-country spread of the virus....

(This article belongs to the Special Issue Global Elimination of Viral Hepatitis)
  • Review
  • Open Access
30 Citations
12,144 Views
30 Pages

Molecular Mechanisms during Hepatitis B Infection and the Effects of the Virus Variability

  • Marina Campos-Valdez,
  • Hugo C. Monroy-Ramírez,
  • Juan Armendáriz-Borunda and
  • Laura V. Sánchez-Orozco

18 June 2021

The immunopathogenesis and molecular mechanisms involved during a hepatitis B virus (HBV) infection have made the approaches for research complex, especially concerning the patients’ responses in the course of the early acute stage. The study of mole...

(This article belongs to the Special Issue Structural Variations and Molecular Genetics of Hepatitis Virus and Related Viruses)
  • Article
  • Open Access
5 Citations
2,975 Views
15 Pages

31 January 2025

Honeybee venom (HBV) is a complex mixture of proteins and enzymes used in traditional medicine to treat various ailments. HBV has multiple pharmacological effects, making it a promising therapeutic agent in several medical areas. In addition, HBV has...

(This article belongs to the Topic Antioxidant Activity of Natural Products—2nd Edition)
  • Case Report
  • Open Access
8 Citations
2,644 Views
10 Pages

Persistently Elevated HBV Viral-Host Junction DNA in Urine as a Biomarker for Hepatocellular Carcinoma Minimum Residual Disease and Recurrence: A Pilot Study

  • Selena Y. Lin,
  • Dina Halegoua-DeMarzio,
  • Peter Block,
  • Yu-Lan Kao and ,
  • Jesse Civan,
  • Fwu-Shan Shieh,
  • Wei Song,
  • Hie-Won Hann and
  • Ying-Hsiu Su
  • + 4 authors+ 0 author

Hepatitis B virus (HBV)-host junction sequences (HBV-JSs) has been detected in the urine of patients with HBV infection. This study evaluated HBV-JSs as a marker of minimum residual disease (MRD) and tumor recurrence after treatment in HBV-hepatocell...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Review
  • Open Access
102 Citations
11,711 Views
17 Pages

24 August 2019

Hepatitis B virus (HBV) reactivation occurs as a major complication of immunosuppressive therapy among persons who have recovered from acute hepatitis and those who have controlled chronic infection. Recent literature data emphasize the presence of a...

(This article belongs to the Special Issue Hepatitis B Virus Reactivation)
  • Article
  • Open Access
12 Citations
3,252 Views
14 Pages

Immune Escape and Drug Resistance Mutations in Patients with Hepatitis B Virus Infection: Clinical and Epidemiological Implications

  • Maria Antonia De Francesco,
  • Franco Gargiulo,
  • Francesca Dello Iaco,
  • Laert Zeneli and ,
  • Serena Zaltron,
  • Giorgio Tiecco,
  • Simone Pellizzeri,
  • Emanuele Focà,
  • Arnaldo Caruso and
  • Eugenia Quiros-Roldan
  • + 5 authors+ 0 author

20 April 2025

Hepatitis B virus (HBV) genetic variability, shaped by high mutation rates and selective pressures, complicates its management and increases the emergence of drug-resistant and immune-escape variants. This study aims to analyze immune escape mutation...

(This article belongs to the Section Epidemiology)
  • Article
  • Open Access
3 Citations
1,645 Views
14 Pages

Utility of Serum HBV RNA Measurement During Nucleoside/Nucleotide Analog Therapy in Chronic Hepatitis B Patients

  • Keiichi Hiraoka,
  • Masataka Tsuge,
  • Michihiko Kawahara,
  • Hatsue Fujino and ,
  • Yasutoshi Fujii,
  • Atsushi Ono,
  • Eisuke Murakami,
  • Tomokazu Kawaoka,
  • Daiki Miki and
  • Shiro Oka
  • + 9 authors+ 4 authors

18 October 2025

Hepatitis B virus (HBV) particles containing HBV RNA are secreted into the blood; these RNA-containing particles are non-infectious byproducts of the replication cycle and are distinct from mature, DNA-containing virions. The proportion of these part...

(This article belongs to the Special Issue 25th Anniversary of IJMS: Updates and Advances in Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
607 Views
13 Pages

24 April 2026

Background: Obstructive jaundice is a common clinical condition, often caused by malignant tumors such as hepatocellular carcinoma (HCC) or cholangiocarcinoma (CCA). Percutaneous transhepatic cholangiodrainage (PTCD) is a widely used intervention met...

(This article belongs to the Section Gastroenterology & Hepatopancreatobiliary Medicine)
  • Review
  • Open Access
37 Citations
31,191 Views
22 Pages

Hepatitis B Virus Molecular Epidemiology, Host-Virus Interaction, Coinfection, and Laboratory Diagnosis in the MENA Region: An Update

  • Duaa W. Al-Sadeq,
  • Sara A. Taleb,
  • Roan E. Zaied,
  • Sara M. Fahad and ,
  • Maria K. Smatti,
  • Balsam R. Rizeq,
  • Asmaa A. Al Thani,
  • Hadi M. Yassine and
  • Gheyath K. Nasrallah
  • + 4 authors+ 0 author

Hepatitis B virus (HBV) is an enveloped partial double-stranded DNA virus that can cause acute and chronic hepatitis. According to the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), 257 million people are li...

  • Article
  • Open Access
1 Citations
4,492 Views
12 Pages

Identifying Childhood Risk Factors for Hepatitis B with a Focus on Vertical Transmission

  • Lorenza Forna,
  • Ancuta Lupu,
  • Laura Bozomitu,
  • Gabriela Paduraru and ,
  • Camelia Cojocariu,
  • Carmen Anton,
  • Irina Girleanu,
  • Cristina Maria Muzica and
  • Anca Trifan
  • + 4 authors+ 0 author

16 September 2024

Background: Despite worldwide vaccination efforts, Hepatitis B virus (HBV) infection remains a significant global health burden, particularly in regions where vertical transmission is prevalent. Given Romania’s history as an endemic area for he...

  • Article
  • Open Access
3 Citations
2,693 Views
14 Pages

Prevalence and Genetic Diversity of Bat Hepatitis B Viruses in Bat Species Living in Gabon

  • Danielle S. Koumba Mavoungou,
  • Linda Bohou Kombila,
  • Neil M. Longo Pendy,
  • Schedy E. Koumba Moukouama and ,
  • Sonia Etenna Lekana-Douki,
  • Gaël D. Maganga,
  • Eric M. Leroy,
  • Avelin F. Aghokeng and
  • Nadine N’dilimabaka
  • + 4 authors+ 0 author

25 June 2024

Hepatitis B virus (HBV) infection leads to around 800,000 deaths yearly and is considered to be a major public health problem worldwide. However, HBV origins remain poorly understood. Here, we looked for bat HBV (BtHBV) in different bat species in Ga...

(This article belongs to the Section Animal Viruses)
  • Article
  • Open Access
9 Citations
5,642 Views
17 Pages

HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets

  • Luna Colagrossi,
  • Romina Salpini,
  • Rossana Scutari,
  • Luca Carioti and ,
  • Arianna Battisti,
  • Lorenzo Piermatteo,
  • Ada Bertoli,
  • Lavinia Fabeni,
  • Carmine Minichini and
  • Valentina Svicher
  • + 30 authors+ 25 authors

9 July 2018

Chronic HBV + HDV infection is associated with greater risk of liver fibrosis, earlier hepatic decompensation, and liver cirrhosis hepatocellular carcinoma compared to HBV mono-infection. However, to-date no direct anti-HDV drugs are available in cli...

(This article belongs to the Section Animal Viruses)
  • Communication
  • Open Access
9 Citations
5,125 Views
10 Pages

12 April 2023

Immunoglobulin new antigen receptor (IgNAR) is a naturally occurring antibody that consists of only two heavy chains with two independent variable domains. The variable binding domain of IgNAR, called variable new antigen receptor (VNAR), is attracti...

(This article belongs to the Section Marine Biotechnology Related to Drug Discovery or Production)
  • Review
  • Open Access
132 Citations
20,416 Views
36 Pages

9 March 2024

Annually, more than 1.5 million preventable new hepatitis B (HBV) infections continue to occur, with an estimated global burden of 296 million individuals living with chronic hepatitis B infection. This substantial health challenge results in over 82...

(This article belongs to the Special Issue Vaccine Efficacy, Impact, Hesitancy and Acceptance: Trends for Public Health)
  • Review
  • Open Access
18 Citations
18,064 Views
14 Pages

11 January 2024

Hepatitis B virus (HBV) reactivation in the setting of immunosuppressive therapy is an increasingly recognized and preventable cause of elevated liver enzymes and clinical hepatitis in treated patients. However, not all immunosuppressive therapies co...

(This article belongs to the Special Issue New Advances in Management of Hepatitis B Virus (HBV) Infection)
  • Article
  • Open Access
12 Citations
3,082 Views
16 Pages

Immunoinformatics and Evaluation of Peptide Vaccines Derived from Global Hepatitis B Viral HBx and HBc Proteins Critical for Covalently Closed Circular DNA Integrity

  • Umar Saeed,
  • Zahra Zahid Piracha,
  • Salman Alrokayan,
  • Tajamul Hussain and ,
  • Fahad N. Almajhdi and
  • Yasir Waheed
  • + 1 author+ 0 author

The Hepatitis B virus (HBV) HBx and HBc proteins play a crucial role in associating with covalently closed circular DNA (cccDNA), the primary factor contributing to intrahepatic viral persistence and a major obstacle in achieving a cure for HBV. The...

(This article belongs to the Special Issue Control and Elimination of Viral Hepatitis)
  • Review
  • Open Access
40 Citations
12,567 Views
16 Pages

Isolated Anti-HBc: Significance and Management

  • Florian MORETTO,
  • François-Xavier CATHERINE,
  • Clémentine ESTEVE,
  • Mathieu BLOT and
  • Lionel PIROTH

11 January 2020

Hepatitis B virus (HBV) infection is prevalent worldwide and is associated with dramatic levels of morbidity and mortality. Isolated anti-HBc (IAHBc) is a particular serological pattern that is commonly found in immunocompromised patients. There is o...

(This article belongs to the Special Issue Immunobiology Pathogenesis and Therapeutic Perspectives in Viral Hepatitis)
  • Article
  • Open Access
4 Citations
4,170 Views
12 Pages

Metabolically Improved Stem Cell Derived Hepatocyte-Like Cells Support HBV Life Cycle and Are a Promising Tool for HBV Studies and Antiviral Drug Screenings

  • Tine Tricot,
  • Hendrik Jan Thibaut,
  • Kayvan Abbasi,
  • Ruben Boon and ,
  • Nicky Helsen,
  • Manoj Kumar,
  • Johan Neyts and
  • Catherine Verfaillie
  • + 3 authors+ 0 author

More than 300 million people worldwide are diagnosed with a chronic hepatitis B virus (HBV) infection. Nucleos(t)ide viral polymerase inhibitors are available on the market and can efficiently treat patients with chronic HBV. However, life-long treat...

(This article belongs to the Special Issue New Challenges in the Study of Liver Diseases: From Molecular Pathogenesis to Therapeutic Approaches)
  • Article
  • Open Access
17 Citations
4,226 Views
15 Pages

Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative Disease

  • Andrea Magri,
  • James M. Harris,
  • Valentina D’Arienzo,
  • Rosalba Minisini and ,
  • Frank Jühling,
  • Peter A. C. Wing,
  • Rachele Rapetti,
  • Monica Leutner,
  • Barbara Testoni and
  • Jane A. McKeating
  • + 9 authors+ 4 authors

17 May 2022

Chronic hepatitis B virus (HBV) infection is a global health problem that presents as a spectrum of liver disease, reflecting an interplay between the virus and the host immune system. HBV genomes exist as episomal covalently closed circular DNA (ccc...

(This article belongs to the Section Human Virology and Viral Diseases)
  • Case Report
  • Open Access
503 Views
18 Pages

Severe HBV-Associated Hepatitis in Infants from the Same Family: Two Clinical Cases with Different Outcomes

  • Petar Vasilev,
  • Zhelyazko Badarov,
  • Angel Todev,
  • Petya Argirova and ,
  • Velina Stoeva,
  • Boriana Chopova,
  • Maria Atanasova,
  • Ivan Baltadzhiev and
  • Mariyana Stoycheva-Vartigova
  • + 4 authors+ 0 author

Acute hepatitis B virus (HBV) infection is rare during infancy, and severe symptomatic HBV-associated hepatitis is even less common. We describe two siblings who developed severe HBV-associated liver injury during infancy, two years apart, but experi...

  • Article
  • Open Access
30 Citations
4,467 Views
16 Pages

The Liver Microbiome Is Implicated in Cancer Prognosis and Modulated by Alcohol and Hepatitis B

  • Jaideep Chakladar,
  • Lindsay M. Wong,
  • Selena Z. Kuo,
  • Wei Tse Li and ,
  • Michael Andrew Yu,
  • Eric Y. Chang,
  • Xiao Qi Wang and
  • Weg M. Ongkeko
  • + 3 authors+ 0 author

21 June 2020

Hepatocellular carcinoma (HCC) is one of the deadliest cancers in the world. Previous studies have identified the importance of alcohol and hepatitis B (HBV) infection on HCC carcinogenesis, indicating synergy in the methods by which these etiologies...

(This article belongs to the Section Cancer Immunology and Immunotherapy)
  • Article
  • Open Access
13 Citations
6,389 Views
31 Pages

In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana

  • Wonderful Tatenda Choga,
  • Motswedi Anderson,
  • Edward Zumbika,
  • Bonolo B. Phinius and ,
  • Tshepiso Mbangiwa,
  • Lynnette N. Bhebhe,
  • Kabo Baruti,
  • Peter Opiyo Kimathi,
  • Kaelo K. Seatla and
  • Simani Gaseitsiwe
  • + 9 authors+ 4 authors

6 July 2020

Hepatitis B virus (HBV) is the primary cause of liver-related malignancies worldwide, and there is no effective cure for chronic HBV infection (CHB) currently. Strong immunological responses induced by T cells are associated with HBV clearance during...

(This article belongs to the Special Issue Hepatitis B Virus: From Diagnostics to Treatments)
  • Feature Paper
  • Article
  • Open Access
9 Citations
4,648 Views
13 Pages

Risk of Non-Hodgkin Lymphoma among Patients with Hepatitis B Virus and Hepatitis C Virus in Taiwan: A Nationwide Cohort Study

  • Yung-Rung Lai,
  • Ya-Lan Chang,
  • Chiu-Hsiang Lee,
  • Tung-Han Tsai and ,
  • Kuang-Hua Huang and
  • Chien-Ying Lee
  • + 1 author+ 0 author

24 January 2022

Hepatitis B virus (HBV) and hepatitis C virus (HCV) are associated with an increased risk of developing non-Hodgkin lymphoma (NHL); however, adequate data corroborating these associations are lacking. Therefore, a study based on the national database...

(This article belongs to the Section Cancer Epidemiology and Prevention)
  • Review
  • Open Access
151 Citations
15,270 Views
16 Pages

Occult Hepatitis B Virus Infection: An Update

  • Carlo Saitta,
  • Teresa Pollicino and
  • Giovanni Raimondo

8 July 2022

Occult hepatitis B virus (HBV) infection (OBI) refers to a condition in which replication-competent viral DNA is present in the liver (with detectable or undetectable HBV DNA in the serum) of individuals testing negative for the HBV surface antigen (...

(This article belongs to the Special Issue Hepatitis B Virus Research in Italy: From Epidemiology to Treatment)
  • Case Report
  • Open Access
3 Citations
2,636 Views
7 Pages

Hepatitis B Virus Reactivation upon Immunosuppression: Is There a Role for Hepatitis B Core-Related Antigen in Patients with Immune-Escape Mutants? A Case Report

  • Gian Paolo Caviglia,
  • Antonella Zorzi,
  • Mario Rizzetto,
  • Massimo Mirandola and ,
  • Antonella Olivero and
  • Giada Carolo
  • + 1 author+ 0 author

24 November 2021

The reactivation of hepatitis B virus (HBVr) in patients undergoing pharmacological immunosuppression is a potentially fatal clinical event that may occur in patients with overt or occult HBV infection. The risk of HBVr is mainly determined by the ty...

(This article belongs to the Section Diagnostic Microbiology and Infectious Disease)
  • Article
  • Open Access
1 Citations
2,715 Views
12 Pages

Factors Associated with Hepatitis B Vaccination Status Among U.S. Adults with Diabetes

  • Douwné L. Müller,
  • Jessica Yingst,
  • William A. Calo,
  • Heather Stuckey and ,
  • Thomas Godfrey and
  • Li Wang
  • + 1 author+ 0 author

1 October 2025

Background/Objectives: Adults aged 19–59 with diabetes are recommended by the Advisory Committee on Immunization Practices (ACIP) to receive vaccination against Hepatitis B Virus (HBV) infection because of their increased risk of contracting HB...

  • Article
  • Open Access
1,357 Views
12 Pages

Hepatitis B in Hemodialysis: Serologic Dynamics and Implications for Care

  • Rawi Hazzan,
  • Nana Peleg,
  • Tarek Saadi,
  • Mahmood Mahajna and ,
  • Maanit Shapira,
  • Yana Tal,
  • Ahlam Bsoul,
  • Oren Gal and
  • Fadi Abu Baker
  • + 4 authors+ 0 author

13 April 2026

Background: Hemodialysis patients are particularly vulnerable to hepatitis B virus (HBV) due to immunosuppression and repeated vascular access. While universal childhood vaccination has reduced population-level HBV prevalence, dialysis units require...

(This article belongs to the Section Infectious Diseases)
  • Article
  • Open Access
931 Views
19 Pages

National Prevalence and Risk Factors of Hepatitis B Virus Infection in Tunisia Two Decades After Vaccine Introduction

  • Ahlem Fourati,
  • Meriem Ben Hadj,
  • Sonia Dhaouadi,
  • Aicha Hechaichi and ,
  • Hejer Letaief,
  • Mouna Safer,
  • Amal Cherif,
  • Farah Saffar,
  • Souhir Chelly and
  • Nissaf Bouafif é p Ben Alaya
  • + 12 authors+ 7 authors

23 April 2026

Background/Objectives: Tunisia lacks recent national data on hepatitis B virus (HBV) prevalence, particularly following the introduction of universal HBV vaccination in 1995. A national HBV seroprevalence study is essential to guide prevention strate...

(This article belongs to the Special Issue Vaccination Against Viral Hepatitis for Prevention and Treatment)
  • Brief Report
  • Open Access
9 Citations
3,665 Views
9 Pages

Atypical Hepatitis B Virus Serology Profile—Hepatitis B Surface Antigen-Positive/Hepatitis B Core Antibody-Negative—In Hepatitis B Virus/HIV Coinfected Individuals in Botswana

  • Bonolo B. Phinius,
  • Motswedi Anderson,
  • Margaret Mokomane,
  • Irene Gobe and ,
  • Wonderful T. Choga,
  • Tsholofelo Ratsoma,
  • Basetsana Phakedi,
  • Gorata Mpebe,
  • Doreen Ditshwanelo and
  • Simani Gaseitsiwe
  • + 8 authors+ 3 authors

13 July 2023

(1) Background: Hepatitis B core antibodies (anti-HBc) are a marker of hepatitis B virus (HBV) exposure; hence, a normal HBV serology profile is characterized by HBV surface antigen (HBsAg) and anti-HBc positivity. However, atypical HBV serologies oc...

(This article belongs to the Special Issue HIV and Co-infections: Updates and Insights, 2nd Edition)
  • Review
  • Open Access
1 Citations
1,389 Views
17 Pages

Accuracy of Diagnostic Investigations in Monitoring Hepatitis B Virus Infection: Strengths, Limitations, and Emerging Biomarkers

  • Laura Iulia Bozomitu,
  • Ancuta Lupu,
  • Vasile Valeriu Lupu,
  • Nicoleta Gimiga and ,
  • Dana Teodora Anton Paduraru,
  • Dana Elena Mîndru,
  • Mihaela Mihai,
  • Carmen Anton,
  • Emil Anton and
  • Lorenza Forna
  • + 7 authors+ 2 authors

In October 2020, the International Coalition to Eliminate Hepatitis B Virus (ICE-HBV) updated the biomarker framework; they underscored major advances in the understanding of viral and immunologic markers, yet highlighted persistent gaps in their cli...

(This article belongs to the Special Issue Advanced Molecular Research on the Diagnosis and Treatment of Chronic Liver Diseases)
  • Article
  • Open Access
926 Views
10 Pages

Objectives: This study aimed to evaluate very low HBV DNA viral load below the limit of quantification and to identify correlational factors in different patient groups, including individuals with chronic hepatitis B (CHB), occult HBV infection (OBI)...

(This article belongs to the Section Microbiology in Human Health and Disease)
  • Article
  • Open Access
7 Citations
4,396 Views
22 Pages

Detection of S-HBsAg Mutations in Patients with Hematologic Malignancies

  • Maria V. Konopleva,
  • Maxim S. Belenikin,
  • Andrei V. Shanko,
  • Alexey I. Bazhenov and ,
  • Sergei A. Kiryanov,
  • Tatyana A. Tupoleva,
  • Maria V. Sokolova,
  • Alexander V. Pronin,
  • Tatyana A. Semenenko and
  • Anatoly P. Suslov
  • + 5 authors+ 0 author

Multiple studies of hepatitis B virus (HBV) genetic variability and its relationship with the disease pathogenesis are currently ongoing, stemming from growing evidence of the clinical significance of HBV mutations. It is becoming increasingly eviden...

(This article belongs to the Section Diagnostic Microbiology and Infectious Disease)
  • Review
  • Open Access
13 Citations
5,768 Views
28 Pages

Hepatitis B Virus and microRNAs: A Bioinformatics Approach

  • Verdiana Zulian,
  • Giulia Fiscon,
  • Paola Paci and
  • Anna Rosa Garbuglia

7 December 2023

In recent decades, microRNAs (miRNAs) have emerged as key regulators of gene expression, and the identification of viral miRNAs (v-miRNAs) within some viruses, including hepatitis B virus (HBV), has attracted significant attention. HBV infections oft...

(This article belongs to the Special Issue Different Functions and Roles of microRNAs in Human Disease—Development, Progress and Challenges)
  • Review
  • Open Access
734 Views
20 Pages

Chronic hepatitis B virus (HBV) infection remains one of the main causes of hepatocellular carcinoma (HCC), even though vaccination and long-term viral suppression have reduced new infections and circulating viral replication. This residual cancer ri...

(This article belongs to the Section Cancer Biology and Oncology)
  • Article
  • Open Access
3 Citations
3,145 Views
15 Pages

Genomic Variability of Hepatitis B Virus Circulating in Brazilian Western Amazon

  • Tárcio Peixoto Roca,
  • Livia Melo Villar,
  • Felipe Souza Nogueira Lima,
  • Mariana Pinheiro Alves Vasconcelos and ,
  • Lourdes Maria Pinheiro Borzacov,
  • Eugênia de Castro e Silva,
  • Bárbara Vieira do Lago,
  • Mayara Torquato Lima da Silva,
  • Luan Felipo Botelho Souza and
  • Deusilene Souza Vieira
  • + 7 authors+ 2 authors

22 September 2022

The emergence of clinically relevant mutations in the hepatitis B virus (HBV) genome has been a matter of great debate because of the possibility of escape from the host’s immune system, the potential to cause more severe progression of liver d...

(This article belongs to the Special Issue Viral Hepatitis in Brazil)
  • Article
  • Open Access
6 Citations
6,974 Views
20 Pages

Metabolic Disorders in Patients with Chronic Hepatitis B Virus Infection: Coffee as a Panacea? (ANRS CO22 Hepather Cohort)

  • Tangui Barré,
  • Hélène Fontaine,
  • Stanislas Pol,
  • Clémence Ramier and ,
  • Vincent Di Beo,
  • Camelia Protopopescu,
  • Fabienne Marcellin,
  • Morgane Bureau,
  • Marc Bourlière and
  • on behalf of the ANRS/AFEF Hepather Study Group
  • + 13 authors+ 8 authors

14 February 2022

People living with chronic hepatitis B virus (HBV) infection are at high risk of liver disease progression, which is positively associated with metabolic disorders, but inversely associated with dyslipidemia. Diet, including dietary antioxidants, is...

(This article belongs to the Special Issue Oxidative Stress and Chronic Liver Diseases)
  • Article
  • Open Access
18 Citations
5,351 Views
30 Pages

Nested Cross-Validation for HBV Conceptual Rainfall–Runoff Model Spatial Stability Analysis in a Semi-Arid Context

  • Mohamed El Garnaoui,
  • Abdelghani Boudhar,
  • Karima Nifa,
  • Yousra El Jabiri and ,
  • Ismail Karaoui,
  • Abdenbi El Aloui,
  • Abdelbasset Midaoui,
  • Morad Karroum,
  • Hassan Mosaid and
  • Abdelghani Chehbouni
  • + 5 authors+ 0 author

10 October 2024

Accurate and efficient streamflow simulations are necessary for sustainable water management and conservation in arid and semi-arid contexts. Conceptual hydrological models often underperform in these catchments due to the high climatic variability a...

(This article belongs to the Special Issue Multi-Source Remote Sensing Data in Hydrology and Water Management)
  • Communication
  • Open Access
12 Citations
5,075 Views
10 Pages

Fast Differentiation of HepaRG Cells Allowing Hepatitis B and Delta Virus Infections

  • Julie Lucifora,
  • Maud Michelet,
  • Anna Salvetti and
  • David Durantel

14 October 2020

HepaRG cells are liver bipotent progenitors acquiring hepatocytes features when differentiated in the presence of dimethylsulfoxide (DMSO). Differentiated HepaRG (dHepaRG) are considered the best surrogate model to primary human hepatocytes (PHH) and...

(This article belongs to the Special Issue Hepatitis B Virus and Host Interactions)
  • Review
  • Open Access
36 Citations
17,791 Views
21 Pages

The hepatitis B surface antigen (HBsAg) is a multifunctional glycoprotein composed of large (LHB), middle (MHB), and small (SHB) subunits. HBsAg isoforms have numerous biological functions during HBV infection—from initial and specific viral at...

(This article belongs to the Special Issue Viral Hepatitis in Europe: The Unresolved Issues)
  • Article
  • Open Access
1 Citations
4,742 Views
12 Pages

Serological Status of Vaccine and Hepatitis B Virus Exposure Among Children Under 5 and Aged 15–17 Years in Kampala, Uganda

  • Fahad Muwanda,
  • Edward Kiyonga,
  • Joan Nambafu,
  • Agnes Turyamubona and ,
  • Hussein Mukasa Kafeero,
  • Edgar Kigozi,
  • Harriet Mupere Babikako,
  • Enock Wekiya,
  • Gerald Mboowa and
  • Bernard Ssentalo Bagaya
  • + 8 authors+ 3 authors

30 October 2024

Background: Pediatric hepatitis B virus (HBV) serostatus remains variably characterized, hardly determined at times, or documented as part of national monitoring of the Extended Programs for Immunization (EPI). Methods: We cross-sectionally character...

  • Article
  • Open Access
10 Citations
3,720 Views
16 Pages

28 March 2022

Cholangiocarcinoma (CCA), especially intrahepatic CCA, is known to share several risk factors with hepatocellular carcinoma (HCC) and liver cirrhosis has been proposed as a common pathogenic factor. We aimed to identify the risk factors of CCA and to...

(This article belongs to the Section Cancer Epidemiology and Prevention)
  • Article
  • Open Access
8 Citations
4,800 Views
13 Pages

The Effect of HBV/HCV in Response to HAART in HIV Patients after 12 Months in Kumba Health District in the South West Region of Cameroon

  • Adamu Ndongho Ndifontiayong,
  • Innocent Mbulli Ali,
  • Jean Baptiste Sokoudjou,
  • Jerimiah Mbogwe Ndimumeh and
  • Christopher Bonglavnyuy Tume

Hepatitis B (HBV) and C (HCV) are two among the numerous forms of infections whose clinical degeneration, morbidity–mortality and low immune responsiveness in people living with human immunodeficiency virus (HIV) are highly evident. Co-infection of H...

(This article belongs to the Section Infectious Diseases)
  • Article
  • Open Access
5 Citations
2,653 Views
11 Pages

Association of Pre-S/S and Polymerase Mutations with Acute and Chronic Hepatitis B Virus Infections in Patients from Rio de Janeiro, Brazil

  • Camilla Rodrigues de Almeida Ribeiro,
  • Katrini Guidolini Martinelli,
  • Vinícius da Motta de Mello,
  • Natália Spitz and ,
  • Oscar Rafael Carmo Araújo,
  • Lia Laura Lewis-Ximenez,
  • Natalia Motta Araujo and
  • Vanessa Salete de Paula
  • + 3 authors+ 0 author

24 June 2022

Several hepatitis B virus (HBV)-related factors, including the viral load, genotype, and genomic mutations, have been linked to the development of liver diseases. Therefore, in this study we aimed to investigate the influence of HBV genetic variabili...

(This article belongs to the Special Issue Viral Hepatitis in Brazil)
  • Article
  • Open Access
211 Views
14 Pages

Ten-Year Outcomes in Liver Transplantation for HBV/HDV Coinfection: A Romanian Single-Center Cohort Study

  • Speranta Iacob,
  • Mirela Chitul,
  • Vlad Brasoveanu,
  • Razvan Cerban and ,
  • Ileana Constantinescu,
  • Bogdan Dorobantu,
  • Carmen Ester,
  • Cristian Gheorghe,
  • Mihaela Ghioca and
  • Liana Gheorghe
  • + 12 authors+ 7 authors

21 October 2026

Background/Objectives: Chronic hepatitis B virus (HBV)/hepatitis D virus (HDV) coinfection is a major cause of cirrhosis and hepatocellular carcinoma (HCC) and remains a disproportionately frequent indication for liver transplantation (LT) in Romania...

(This article belongs to the Section Gastroenterology & Hepatopancreatobiliary Medicine)
  • Article
  • Open Access
35 Citations
4,693 Views
16 Pages

Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen

  • Mary C. Kuhns,
  • Vera Holzmayer,
  • Mark Anderson,
  • Anne L. McNamara and ,
  • Silvia Sauleda,
  • Dora Mbanya,
  • Pham T. Duong,
  • Nguyen T. T. Dung and
  • Gavin A. Cloherty
  • + 4 authors+ 0 author

13 October 2021

Background: Gaps remain in the detection of nucleic acid test (NAT) yield and occult hepatitis B virus (HBV) infection (OBI) by current HBV surface antigen (HBsAg) assays. The lack of detection may be due to HBsAg levels below current assay detection...

(This article belongs to the Special Issue Recent Advances in Management of Hepatitis B and towards Achieving a HBV Cure)
  • Communication
  • Open Access
18 Citations
3,662 Views
10 Pages

Immune-Escape Mutations Are Prevalent among Patients with a Coexistence of HBsAg and Anti-HBs in a Tertiary Liver Center in the United States

  • Mukarram Jamat Ali,
  • Pir Ahmed Shah,
  • Khalil Ur Rehman,
  • Satinder Kaur and ,
  • Vera Holzmayer,
  • Gavin A. Cloherty,
  • Mary C. Kuhns and
  • Daryl T. Y. Lau
  • + 3 authors+ 0 author

30 April 2024

The concurrent seropositivity of HBsAg and anti-HBs has been described among patients with chronic hepatitis B (CHB), but its prevalence is variable. HBV S-gene mutations can affect the antigenicity of HBsAg. Patients with mutations in the ‘&al...

(This article belongs to the Special Issue Viral Genetic Variation)
  • Article
  • Open Access
6 Citations
4,149 Views
11 Pages

Seroprevalence Study of Anti-HBs Antibodies in the General Population of Vojvodina, Serbia

  • Smiljana Rajčević,
  • Snežana Medić,
  • Aleksandra Patić,
  • Nataša Dragnić and ,
  • Mioljub Ristić,
  • Vladimir Vuković and
  • Vladimir Petrović
  • + 2 authors+ 0 author

6 March 2024

Background and Objectives: Hepatitis B (HB) is a major global health problem and a potentially life-threatening disease caused by the hepatitis B virus (HBV). Also, it is an important cause of morbidity and mortality worldwide. Thanks to serological...

(This article belongs to the Section Epidemiology & Public Health)
  • Article
  • Open Access
5 Citations
3,341 Views
12 Pages

Hepatitis B Immunization Status in Children with Chronic Kidney Disease: Experience at a Single Center, Egypt

  • Doaa Mohammed Youssef,
  • Amal S. El-Shal,
  • Rabab M. Elbehidy,
  • Mohamed Adel Fouda and ,
  • Sally M. Shalaby,
  • Lamiaa Lotfy El Hawy,
  • Abdelrahman Fathi Elsadek,
  • Mayy Abd Alfattah Neemat-Allah,
  • Seham M. Ramadan and
  • Mona Hamed Gehad
  • + 11 authors+ 6 authors

27 February 2023

Background: Children with chronic kidney disease (CKD), particularly those who require hemodialysis (HD), are at high risk of hepatitis B virus (HBV) infection. The HBV vaccine non-/hypo-response rate among HD children remains high, and it is critica...

(This article belongs to the Section Gastroenterology & Hepatopancreatobiliary Medicine)
  • Article
  • Open Access
5 Citations
4,063 Views
22 Pages

Deep Learning Prediction of Streamflow in Portugal

  • Rafael Francisco and
  • José Pedro Matos

19 December 2024

The transformative potential of deep learning models is felt in many research fields, including hydrology and water resources. This study investigates the effectiveness of the Temporal Fusion Transformer (TFT), a deep neural network architecture for...

(This article belongs to the Special Issue Editorial Board Members’ Collection Series: The Flood Estimation and Forecasting Chain: Meteorological–Hydrological–Hydraulic Forecasts and Predictive Uncertainty towards Operational Decisions)

of 2